Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for vincristine-induced polyneuropathy in children with cancer
IRCT20230626058586N8Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Duloxetine group with Placebo group (2 arms). Primary endpoints: Neuropathy symptom level, Emotional and behavioral symptoms and 1 more. Started Dec 2024; status: completed.
02
Drugs
duloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20230626058586N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230626058586N8.